TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer
Abstract Neuroendocrine differentiation (NED) is associated with WNT signaling activation and can be significantly observed after failure of androgen-deprivation therapy (ADT) for prostatic adenocarcinomas. Cytokine signaling is stimulated in NED prostate cancer; however, how ADT-upregulated WNT sig...
Guardado en:
Autores principales: | Yu-Ching Wen, Yen-Nien Liu, Hsiu-Lien Yeh, Wei-Hao Chen, Kuo-Ching Jiang, Shian-Ren Lin, Jiaoti Huang, Michael Hsiao, Wei-Yu Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99d5960710964c0a90f14edae6b01add |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
por: Wei-Yu Chen, et al.
Publicado: (2021) -
Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021) -
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
por: En-Chi Hsu, et al.
Publicado: (2021) -
ONECUT2 is a driver of neuroendocrine prostate cancer
por: Haiyang Guo, et al.
Publicado: (2019) -
Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation
por: Chuntao Zhao, et al.
Publicado: (2016)